Comparing the Top Two: Eaton Vance Corporation (NYSE:EV), Magellan Health, Inc. (NASDAQ:MGLN)

stock overview

Eaton Vance Corporation (NYSE:EV)

Eaton Vance Corporation (NYSE:EV) closed at $43.95 on the last trading session with an decrease of -4.16%, whereas, it previously closed at $45.86. The company has a market capitalization of $5.12 Billion. The company traded shares of 695296 on the trading day while its three month average volume stands at 533.11 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Eaton Vance Corporation (NYSE:EV) produced diluted EPS of 3.5. The EPS estimate for next year as estimated by analysts is at 3.81 while EPS for next quarter is estimated at 0.85. Earnings per Share growth for this year is reported at 5.8, while the analysts estimated the EPS growth for next year at 3.81% and Earnings growth for next 5 years stands at 3.16% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 7.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Eaton Vance Corporation (NYSE:EV) is at 12.55 while the forward p/e is at 11.55. The P/S or Price to Sales ratio of Eaton Vance Corporation (NYSE:EV) stands at 3.04 and Price to Book or P/B for the most recent quarter stands at 4.03. The Price to Free Cash Flow ratio or P/FCF is reported at 16.11. The quick ratio and the current ratio of Eaton Vance Corporation (NYSE:EV) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Eaton Vance Corporation (NYSE:EV) stands at 10.4, 35.8 and 11.3 respectively

The trailing twelve month Revenue of Eaton Vance Corporation (NYSE:EV) is reported at 1.68 Billion with income of 400 Million. The outstanding shares of Eaton Vance Corporation (NYSE:EV) are 116.5 Million. The institutional Ownership of the shares of 72.2 stands at 0.80%, this figure is increased 0.46 in the last six months. The insider ownership for the shares of Eaton Vance Corporation (NYSE:EV) is ticked at 3.6%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Eaton Vance Corporation (NYSE:EV) is the Mean Target Price estimated by the analysts which stands at 49.75. The 52 week high of Eaton Vance Corporation (NYSE:EV) is placed at 51.79 and 52 week low is standing at 36.84.

Performance wise the shares of Eaton Vance Corporation (NYSE:EV) fell down -14.96% for the week, it also fell -5.73% for the monthly performance, while for the quarter it went up -9.72%. The shares increase 8.63% for the half year and plummeted for the Year-To-Date performance. The shares of Eaton Vance Corporation (NYSE:EV) grew 4.05% for the yearly performance.

Magellan Health, Inc. (NASDAQ:MGLN)

Magellan Health, Inc. (NASDAQ:MGLN) closed at $65.52 on the last trading session with an decrease of -2.4%, whereas, it previously closed at $67.13. The company has a market capitalization of $1.61 Billion. The company traded shares of 186808 on the trading day while its three month average volume stands at 136.72 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Magellan Health, Inc. (NASDAQ:MGLN) produced diluted EPS of 0.27. The EPS estimate for next year as estimated by analysts is at 4.7 while EPS for next quarter is estimated at 0.98. Earnings per Share growth for this year is reported at -77.1, while the analysts estimated the EPS growth for next year at 4.7% and Earnings growth for next 5 years stands at -1.3% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -26.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Magellan Health, Inc. (NASDAQ:MGLN) is at 247.25 while the forward p/e is at 13.93. The P/S or Price to Sales ratio of Magellan Health, Inc. (NASDAQ:MGLN) stands at 0.22 and Price to Book or P/B for the most recent quarter stands at 1.17. The Price to Free Cash Flow ratio or P/FCF is reported at 7.54. The quick ratio and the current ratio of Magellan Health, Inc. (NASDAQ:MGLN) are reported at 1.6 and 1.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Magellan Health, Inc. (NASDAQ:MGLN) stands at 0.2, 0.6 and 2.2 respectively

The trailing twelve month Revenue of Magellan Health, Inc. (NASDAQ:MGLN) is reported at 7.2 Billion with income of 7.7 Million. The outstanding shares of Magellan Health, Inc. (NASDAQ:MGLN) are 24.64 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 2.82 in the last six months. The insider ownership for the shares of Magellan Health, Inc. (NASDAQ:MGLN) is ticked at 0.2%, the figure is plummeted -38.96% in the last six months.

Some other important financial aspects to be discussed here for Magellan Health, Inc. (NASDAQ:MGLN) is the Mean Target Price estimated by the analysts which stands at 80. The 52 week high of Magellan Health, Inc. (NASDAQ:MGLN) is placed at 81.04 and 52 week low is standing at 57.79.

Performance wise the shares of Magellan Health, Inc. (NASDAQ:MGLN) fell down -10.81% for the week, it also fell -11.82% for the monthly performance, while for the quarter it went up -17.41%. The shares increase 6.8% for the half year and plummeted for the Year-To-Date performance. The shares of Magellan Health, Inc. (NASDAQ:MGLN) shrinked -2.21% for the yearly performance.